Country: Malta
Language: English
Source: Medicines Authority
RAMIPRIL
Aurobindo Pharma (Malta) Limited Vault 14, Level 2, Valletta Waterfront, Floriana FRN 1913, Malta
C09AA05
RAMIPRIL 1.25 mg
TABLET
RAMIPRIL 1.25 mg
POM
AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
Authorised
2012-12-03
PACKAGE LEAFLET: INFORMATION FOR THE USER RAMIPRIL AUROBINDO 1.25 MG TABLETS RAMIPRIL AUROBINDO 2.5 MG TABLETS RAMIPRIL AUROBINDO 5 MG TABLETS RAMIPRIL AUROBINDO 10 MG TABLETS Ramipril READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Ramipril Aurobindo is and what it is used for 2. What you need to know before you take Ramipril Aurobindo 3. How to take Ramipril Aurobindo 4. Possible side effects 5. How to store Ramipril Aurobindo 6. Contents of the pack and other information 1. WHAT RAMIPRIL AUROBINDO IS AND WHAT IT IS USED FOR Ramipril Aurobindo contains the active substance called ramipril. This belongs to a group of medicines called ACE inhibitors (Angiotensin Converting Enzyme Inhibitors). Ramipril Aurobindo works by: • Decreasing your body’s production of substances that could raise your blood pressure • Making your blood vessels relax and widen • Making it easier for your heart to pump blood around your body. Ramipril Aurobindo can be used: • To treat high blood pressure (hypertension) • To reduce the risk of you having a heart attack or stroke • To reduce the risk or delay the worsening of kidney problems (whether or not you have diabetes) • To treat your heart when it cannot pump enough blood to the rest of your body (heart failure) • As treatment following heart attack (myocardial infarction) complicated with heart failure. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE RAMIPRIL AUROBINDO DO NOT TAKE RAMIPRIL AUROBINDO • If you are allergic to ramipril, any other ACE inhi Read the complete document
Page 1 of 20 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Ramipril Aurobindo 1.25 mg tablets Ramipril Aurobindo 2.5 mg tablets Ramipril Aurobindo 5 mg tablets Ramipril Aurobindo 10 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 1.25 mg ramipril. Each tablet contains 2.5 mg ramipril. Each tablet contains 5 mg ramipril. Each tablet contains 10 mg ramipril. _Excipients with known effect: _ Each tablet contains 12.1 mg lactose monohydrate. Each tablet contains 10.8 mg lactose monohydrate. Each tablet contains 21.7 mg lactose monohydrate. Each tablet contains 43.4 mg lactose monohydrate. For the full list of excipients, see Section 6.1 3. PHARMACEUTICAL FORM Tablet _Ramipril Aurobindo 1.25 mg tablets: _ White to Off-white coloured, flat faced bevel edged round [diameter 5.0] uncoated tablet debossed with “H” and “17” on one side and plain on other side _ _ _Ramipril Aurobindo 2.5 mg tablets: _ Light yellow to yellow coloured, flat faced bevel edged round [diameter 5.0] uncoated tablet debossed with “H” and “18” separated by scoreline on one side and plain on other side. The tablet can be divided into two equal doses. _ _ _Ramipril Aurobindo 5 mg tablets: _ Light pink coloured mottled, flat faced bevel edged round [diameter 6.0] uncoated tablet debossed with “H” and “19” separated by scoreline on one side and plain on other side. The tablet can be divided into two equal doses. _Ramipril Aurobindo 10 mg tablets: _ White to Off-white colored, flat faced bevel edged round [diameter 8.0] uncoated tablet debossed with “H” and “20” separated by scoreline on one side and plain on other side. The tablet can be divided into two equal doses. Page 2 of 20 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS - Treatment of hypertension - Cardiovascular prevention: reduction of cardiovascular morbidity and mortality in patients with: manifest atherothrombotic cardiovascular disease (history of coronary heart disease or stroke, or peripheral vascu Read the complete document